[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Invited Commentary
July 2013

Overcoming Specialty BiasAnother Important Reason for Multidisciplinary Management of Soft Tissue Sarcoma

Author Affiliations
  • 1Surgical Outcomes and Quality Improvement Center, Division of Surgical Oncology, Department of Surgery, Feinberg School of Medicine, and Northwestern Institute for Comparative Effectiveness Research in Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois
JAMA Surg. 2013;148(7):640. doi:10.1001/jamasurg.2013.143

Using a national survey of sarcoma experts with an exceptionally high response rate, Wasif and colleagues1 present an interesting study designed to evaluate whether physician specialty influences adjuvant treatment recommendations in the multidisciplinary management of soft tissue sarcoma and the perceived benefit of these modalities. They reveal a specialty bias in treatment recommendations for soft tissue sarcoma of the extremities that provides unique insights into understanding the existing variation in treatment approaches for this relatively rare disease.

First Page Preview View Large
First page PDF preview
First page PDF preview